Calcium Chloride Injection

[22 November 2016]

Products Affected - Description

Calcium chloride intravenous injection, American Regent
100 mg/mL, 10 mL vial, 25 count (NDC 00517-2710-25) 
Calcium chloride intravenous injection, Hospira
100 mg/mL, 10 mL Ansyr syringe, 10 count (NDC 00409-1631-10)

Reason for the Shortage

  • American Regent has calcium chloride on shortage due to manufacturing delays.
  • Amphastar has calcium chloride available.
  • Hospira has calcium chloride on shortage due to manufacturing delays.
  • Mylan Institutional has withdrawn calcium chloride syringes from the market. The company recalled the syringes in April 2015 due to incompatibility of the syringes and some needless adaptors.

Available Products

Calcium chloride intravenous injection, Amphastar
100 mg/mL, 10 mL Luer-Jet syringe, 10 count (NDC 76329-3304-01)

Calcium chloride intravenous injection, Hospira
100 mg/mL, 10 mL LifeShield syringe, 10 count (NDC 00409-4928-34)

Estimated Resupply Dates

  • American Regent has calcium chloride 100 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
  • Hospira has calcium chloride 100 mg/mL 10 mL Ansyr syringes available in limited supply.

Related Shortages


November 22 and 1, August 24 and 15, July 19, May 16, April 8, March 2, February 1, 2016; December 23, November 9, September 17, July 15, June 17, May 11, April 16, February 27, January 16, 2015; December 18, November 21, October 23, September 11, August 7, May 8, February 26, January 13, 2014; November 15, September 27, August 26, July 16, June 10, May 24, April 23, March 25, February 26, January 23, 2013; December 31, November 6, September 27, August 16 and 1, July 25, June 27, May 22, April 19, March 5, February 22, January 27, 2012; December 13, November 29, October 31, September 28, August 2, July 22, June 1, May 2, April 29, March 14, February 15, January 28, 2011; December 21, November 16, October 22, September 20, August 11, July 19, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing